Results 231 to 240 of about 215,661 (393)

Chronic Central Melanocortin-4 Receptor Antagonism and Central Neuropeptide-Y Infusion in Rats Produce Increased Adiposity by Divergent Pathways [PDF]

open access: bronze, 2002
Katherine Baran   +5 more
openalex   +1 more source

The pharmacotherapeutic potential of neuropeptide Y for chronic pain

open access: yesJournal of Internal Medicine, EarlyView.
Abstract Chronic pain is a major medical problem that requires new therapeutic options. Discovered by Victor Mutt in 1982, neuropeptide Y (NPY) is rapidly emerging as a master regulator of pain relief. Genetic knockdown of NPY or pharmacological inhibition of its receptors demonstrates that NPY signaling tonically inhibits indices of chronic ...
Al A. Nie, Bradley K. Taylor
wiley   +1 more source

A potent Neuropeptide Y (NPY) receptor antagonist 1229U91 suppresses spontaneous food intake in Zucker fatty rats

open access: gold, 1997
Akane Ishihara   +12 more
openalex   +1 more source

Variants in the 5′ region of the neuropeptide Y receptor Y2 gene (NPY2R) are associated with obesity in 5,971 white subjects

open access: yesDiabetologia, 2006
S. Torekov   +8 more
semanticscholar   +1 more source

MRI‐based surrogates of brain clearance in narcolepsy type 1

open access: yesJournal of Sleep Research, EarlyView.
Summary Brain clearance involves the drainage of waste molecules from the brain, a process that is suggested to be amplified during sleep. Recently proposed MRI‐based methods attempt to approximate human brain clearance with surrogate measures. The current study aimed to explore whether two brain clearance surrogates are altered in narcolepsy.
Eva M. van Heese   +6 more
wiley   +1 more source

Central relaxin-3 administration causes hyperphagia in male Wistar rats. [PDF]

open access: yes, 2005
B. M. C. McGowan   +35 more
core   +1 more source

Home - About - Disclaimer - Privacy